Parse Biosciences, a QIAGEN company and the leading provider of scalable and accessible single-cell sequencing solutions, today announced the commercial availability of Evercode™ Whole Transcriptome ...

The single-cell genomics industry does not stop advancing, with a steady stream of new companies, kits, acquisitions, and more. One new company, ArgenTag, was founded in Argentina during the COVID-19 ...

Scientists in China have unveiled a breakthrough way to mass-produce powerful cancer-fighting immune cells in the lab. By engineering early-stage stem cells from cord blood—rather than trying to ...

A new “non-kinetic effects cell” has helped push cyber operations to the forefront of specialized U.S. military missions such as the capture of Venezuela's leader in the capital of Caracas, a top ...

New cell and gene therapies (CGTs) are offering great promise and tremendous challenges for the US healthcare system but with shocking initial costs. For example, gene therapy with exagamglogene ...

Spatial transcriptomics (ST) technologies reveal the spatial organization of gene expression in tissues, providing critical insights into development, neurobiology, and cancer. However, the high cost ...

The robots, each the size of a single cell, casually turn circles in a bath of water. Suddenly, their sensors detect a change: Parts of the bath are heating up. The microrobots halt their twirls and ...

Single-cell RNA sequencing (scRNA-seq) has generated a rapidly expanding collection of public datasets that provide insight into development, disease, and therapy. However, researchers lack an ...

Search and rescues are at risk because of unpaid U.S. Coast Guard and their utilities due to the DHS shutdown ...